Percutaneous Mechanical Circulatory Support Devices Market Outlook 2026–2035: Growth Drivers and Industry Forecast

Global Percutaneous Mechanical Circulatory Support Devices Market

Uncover key drivers, emerging technologies, and competitive movements shaping the worker heat stress monitoring wearable market from 2026–2035 with trusted insights from The Business Research Company

Starting from its 2026 valuation, what market size is the Percutaneous Mechanical Circulatory Support Devices Market expected to reach by 2030?

The percutaneous mechanical circulatory support devices market has experienced robust expansion in recent years. Its value is projected to climb from $2.46 billion in 2025 to $2.7 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.7%. This historical growth has been driven by an increasing burden of cardiovascular diseases, a rise in cardiogenic shock incidents, the widespread adoption of minimally invasive procedures, the expansion of intensive care unit (ICU) services, and an aging global population.

The percutaneous mechanical circulatory support devices market is anticipated to experience substantial expansion over the coming years. This market is projected to reach a valuation of $3.87 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.4%. Several factors are contributing to this growth during the forecast period, including AI-assisted cardiac monitoring, an increase in complex cardiac interventions, the expansion of cath lab procedures, a rising demand for temporary heart support, and advancements in pump technologies. Furthermore, significant trends expected during this period involve minimally invasive cardiac support, short-term hemodynamic assistance, support devices for high-risk PCI procedures, rapid deployment cardiac systems, and designs focused on enhanced patient safety.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20921&type=smp

What Drivers Are Driving Adoption Within The Percutaneous Mechanical Circulatory Support Devices Market?

The rising occurrence of cardiovascular diseases is anticipated to fuel the expansion of the percutaneous mechanical circulatory support devices market in the foreseeable future. Cardiovascular diseases (CVDs) encompass various conditions impacting the heart and blood vessels, such as coronary artery disease, heart attacks, heart failure, stroke, and high blood pressure. This growing prevalence of cardiovascular diseases stems from factors like an aging population, poor lifestyle habits, obesity, high blood pressure, and genetic susceptibility. Percutaneous mechanical circulatory support devices find application in cardiovascular diseases to enhance heart function, lessen cardiac strain, and aid recuperation during severe heart ailments. For example, data from October 2024, provided by the Centers for Disease Control and Prevention, a US-based public health institute, revealed that in 2023, approximately 1 out of every 6 deaths due to cardiovascular diseases occurred in adults younger than 65 years old, with a total of 919,032 people succumbing to cardiovascular disease, accounting for 1 in every 3 deaths. Consequently, the rising occurrence of cardiovascular diseases is propelling the expansion of the percutaneous mechanical circulatory support (MCS) devices market.

How Is The Percutaneous Mechanical Circulatory Support Devices Market Organized Into Various Segments?

The percutaneous mechanical circulatory support devices market covered in this report is segmented –

1) By Product Type: Intra-Aortic Balloon Pumps, Impella Devices, Extracorporeal Membrane Oxygenation, TandemHeart, Other Types

2) By Application: Cardiogenic Shock, Acute Myocardial Infarction, Heart Failure, Other Applications

3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End Users

Subsegments:

1) By Intra-Aortic Balloon Pumps (IABP): Standard IABP Devices, Enhanced IABP Devices

2) By Impella Devices: Impella 2.5, Impella 5.0, Impella CP (Cardiac Power)

3) By Extracorporeal Membrane Oxygenation (ECMO): Veno-Venous ECMO (VV ECMO), Veno-Arterial ECMO (VA ECMO)

4) By Tandemheart: Tandemheart PUMP System, Tandemheart PRO System

5) By Other Types: Centrifugal Pumps, Pneumatic Assist Devices

What Trends Are Reshaping The Dynamics Of The Percutaneous Mechanical Circulatory Support Devices Market?

Leading companies within the percutaneous mechanical circulatory support devices market are concentrating on developing technologically advanced solutions, such as intra-aortic axial-flow devices, to improve patient outcomes and minimize surgical risks. An intra-aortic axial-flow device is a category of percutaneous mechanical circulatory support (MCS) device specifically engineered to aid heart function by increasing blood flow from the left ventricle into the aorta. For instance, in February 2023, Procyrion, Inc., a US-based medical device firm, announced the successful initial human use of its Aortix pump. This innovative device aims to prevent acute kidney injury (AKI) in individuals undergoing cardiac surgery. Delivered through a catheter in the descending thoracic aorta, the Aortix pump enhances renal perfusion while simultaneously reducing the heart’s workload during the surgical procedure. It achieves this by improving both renal and systemic perfusion while decreasing the strain on the heart, making it particularly advantageous for patients with compromised left ventricular function and renal impairment. Capable of providing up to 5.0 liters of flow per minute, the Aortix pump is designed for temporary application during procedures like percutaneous coronary interventions (PCI).

Who Are The Top-Performing Companies In The Percutaneous Mechanical Circulatory Support Devices Market In Recent Years?

Major companies operating in the percutaneous mechanical circulatory support devices market are Abbott Laboratories, Medtronic Plc, Getinge AB, Teleflex Incorporated, Biotronik, Abiomed Inc., LivaNova Plc, Bioventrix, Berlin Heart, Eurosets, Magenta Medical Ltd, SynCardia Systems LLC, CardiacAssist Inc., Jarvik Heart Inc., Procyrion, BiVACOR Inc., CardioBridge GmbH and Company, Circulite Medical Inc., NovaPump GmbH, Supira Medical Inc., Pulsatile Technologies Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/percutaneous-mechanical-circulatory-support-devices-global-market-report

How Does The Percutaneous Mechanical Circulatory Support Devices Market Perform Across Major Global Regions?

North America was the largest region in the percutaneous mechanical circulatory support devices market in 2025. The regions covered in the percutaneous mechanical circulatory support devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Percutaneous Mechanical Circulatory Support Devices Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20921&type=smp

Browse Through More Reports Similar to the Global Percutaneous Mechanical Circulatory Support Devices Market 2026, By The Business Research Company

Peripheral Vascular Devices And Equipment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-vascular-devices-and-equipment-global-market-report

Cardiovascular Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiovascular-devices-global-market-report

Cardiac Assist Devices And Equipment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/cardiac-assist-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company